Reviving UK investment is among the most pressing challenges facing Britain. Rachel Reeves plans to raise the issue in her ...

(Reuters) -AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as ...

AstraZeneca Pharma shares rose after the company received regulatory approval to expand the use of its cancer drug Imfinzi ...

FRANKFURT: European shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed ...

EUROPEAN shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed uncertainty over US trade deals with the July tariff deadline fast approaching and ...

European shares fell on Tuesday on the back of poor performances from the banking and defence sectors, as uncertainty ...

The Dow Jones Industrial Average rose sharply on Tuesday (July 1), gaining 401 points or 0.9%, as investors rotated out of ...

(Reuters) -European shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed ...

AstraZeneca also unveiled a plan to assist 30 Shanghai enterprises to go global in 2024. The plan will cover emerging markets involved in the Belt and Road Initiative as well as the US, Japan, and ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

Europe's military capabilities remain heavily reliant on the US, while both Russia and China have substantially advanced ...

A sign of the CDC is seen on a podium during the meeting of the members of the Advisory Committee on Immunization Practices, ...